These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8787884

  • 41. Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir.
    De Bony F, Tod M, Bidault R, On NT, Posner J, Rolan P.
    Antimicrob Agents Chemother; 2002 Feb; 46(2):458-63. PubMed ID: 11796358
    [Abstract] [Full Text] [Related]

  • 42. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
    Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S, Chambers LO, Robinson JM, Corey L.
    J Infect Dis; 1998 Sep; 178(3):603-10. PubMed ID: 9728526
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
    Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.
    Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952
    [Abstract] [Full Text] [Related]

  • 45. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.
    Engström M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L.
    Lancet Neurol; 2008 Nov 15; 7(11):993-1000. PubMed ID: 18849193
    [Abstract] [Full Text] [Related]

  • 46. Pharmacokinetics of acyclovir in the cat.
    Owens JG, Nasisse MP, Tadepalli SM, Dorman DC.
    J Vet Pharmacol Ther; 1996 Dec 15; 19(6):488-90. PubMed ID: 8971679
    [No Abstract] [Full Text] [Related]

  • 47. Acyclovir concentrations in human breast milk after valaciclovir administration.
    Sheffield JS, Fish DN, Hollier LM, Cadematori S, Nobles BJ, Wendel GD.
    Am J Obstet Gynecol; 2002 Jan 15; 186(1):100-2. PubMed ID: 11810093
    [Abstract] [Full Text] [Related]

  • 48. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir.
    Strand A, Patel R, Wulf HC, Coates KM, International Valaciclovir HSV Study Group.
    Sex Transm Infect; 2002 Dec 15; 78(6):435-9. PubMed ID: 12473805
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 51. A retrospective study on the clinical outcome of herpes zoster in patients treated with acyclovir or valaciclovir vs. patients not treated with antiviral.
    Goh CL, Khoo L.
    Int J Dermatol; 1998 Jul 01; 37(7):544-6. PubMed ID: 9679698
    [No Abstract] [Full Text] [Related]

  • 52. Aciclovir and its l-valyl ester, valaciclovir.
    Smiley ML, Murray A.
    Curr Probl Dermatol; 1996 Jul 01; 24():209-18. PubMed ID: 8743272
    [No Abstract] [Full Text] [Related]

  • 53. Multiple oral dosing of valacyclovir in horses and ponies.
    Garré B, Baert K, Nauwynck H, Deprez P, De Backer P, Croubels S.
    J Vet Pharmacol Ther; 2009 Jun 01; 32(3):207-12. PubMed ID: 19646083
    [Abstract] [Full Text] [Related]

  • 54. [Epilepticus status and valaciclovir in chronic renal failure].
    Rodríguez Uranga JJ, Franco Macías E, Delgado López F, Villalobos Chávez F.
    Med Clin (Barc); 2004 Sep 25; 123(10):399. PubMed ID: 15482711
    [No Abstract] [Full Text] [Related]

  • 55. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 25; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 56. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ, Balimane PV.
    Biopharm Drug Dispos; 1998 May 25; 19(4):209-17. PubMed ID: 9604120
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].
    Helldén A, Bergman U, Dwyer R, Medin C, Molanaei H, Ståhle L, Thylén P, Odar-Cederlöf I.
    Lakartidningen; 1998 May 25; 104(24-25):1916-20. PubMed ID: 17674672
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.